Tom's Hospital vs Insight

Tom's Hospital gives you on-demand AI medical consultations across 15 specialties, from cardiology and oncology to psychiatry and pediatrics. You describe symptoms or upload blood test reports, and the system returns plain-language explanations and next steps based on WHO guidelines. It also covers AHA and ESMO standards, and works as a pre-consultation prep tool or a second opinion after seeing a doctor.

Most symptom checkers give generic answers from a single general model. Tom's Hospital routes you to specialty-specific AI consultants covering cardiology, dentistry, ENT, gastroenterology, gynecology, nephrology, neurology, nutrition, oncology, ophthalmology, orthopedics, pediatrics, psychiatry, psychology, and rheumatology. Blood report analysis handles CBC, thyroid, vitamin D, liver, kidney, and full body checkups with explanations a non-medical reader can follow.

The platform targets patients in the EU, UK, USA, Canada, and Australia who want faster clarity on symptoms or lab results without waiting days for an appointment. A single yearly subscription at $150 covers unlimited consultations and report analyses, costing less than $0.50 per day. Tom's Hospital is SOC2 and GDPR compliant, available 24/7 on any device, and explicitly does not replace in-person medical exams.

Insight is a medical research platform that helps scientists move from a research question to literature-backed summaries, hypotheses, and structured experiment plans. You define a medical research objective, and the platform runs tasks against peer-reviewed biomedical databases to build cited outputs. It is free to try, with optional registration to save objectives on a personal dashboard.

The workflow centers on iterative research cycles. After you submit an objective, Insight outlines a plan in its Thoughts output, then executes tasks against integrated sources including PubMed, NIH RePORTER, ClinicalTrials.gov, MyGene, and MyVariant. Each completed cycle refines the plan and deepens the scientific summary, hypotheses, and citations tied to your question.

Insight Research is available now for literature review, hypothesis generation, and experimental design drafting. Insight Discovery, a separate high-throughput module for target and biomarker identification, remains waitlist-only. The platform is built for researchers in drug discovery, clinical research, and genetics who want structured assistance without manually searching across separate NIH and genomic databases.

Founded in August 2023, Insight positions itself as an accessible research studio for medical scientists. The team publishes documentation, offers email and Discord support, and integrates data sources spanning more than 36 million PubMed articles, 22 million genes, and 400 million human variants.